Nxera Pharma Co., Ltd. (TYO:4565)
Japan · Delayed Price · Currency is JPY 1,130.00
+14.00 (1.25%)
Aug 27, 2026, 11:04 AM JST
Nxera Pharma Financials Overview
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 33,431 | 29,615 | 28,835 | 12,766 | 15,569 | 17,712 |
Revenue Growth | 7.12% | 2.71% | 125.87% | -18.00% | -12.10% | 100.32% |
Gross Profit Gross Profit Growth | 25,425 | 21,417 | 21,219 | 9,664 | 14,643 | 16,779 |
Operating Income Operating Income Growth | -3,631 | -8,269 | -6,624 | -10,399 | 2,812 | 6,910 |
Net Income Net Income Growth | -7,802 | -12,530 | -4,838 | -7,193 | 382 | 1,017 |
Earnings Per Share EPS Growth | -86.14 | -138.80 | -53.92 | -87.18 | 4.63 | 12.40 |
EPS Growth | - | - | - | - | -62.66% | -33.30% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Japan Japan Growth | 17,967 | 14,058 | 6,173 | 80 | -22 |
United Kingdom United Kingdom Growth | 1,773 | 696 | 4 | 142 | 1,178 |
Others Others Growth | 74 | - | - | - | - |
United States of America United States of America Growth | 4,886 | 7,950 | 1,373 | 9,934 | 13,937 |
Switzerland Switzerland Growth | 2,169 | 2,190 | 4,004 | 2,564 | 2,311 |
Bermuda Bermuda Growth | 1,405 | 1,160 | 1,212 | 2,849 | 301 |
Germany Germany Growth | 1,340 | 2,781 | - | - | - |
Total Total Growth | 29,614 | 28,835 | 12,766 | 15,569 | 17,712 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 17,748 | 20,365 | 36,203 | 49,065 | 66,557 | 60,087 |
Total Debt Total Debt Growth | 54,406 | 57,379 | 67,900 | 73,973 | 29,734 | 29,271 |
Net Cash (Debt) Net Cash Growth | -36,658 | -37,014 | -31,697 | -24,908 | 36,823 | 30,816 |
Net Cash Growth | - | - | - | - | 19.49% | 31.78% |
Net Cash Per Share Net Cash Per Share Growth | -404.62 | -410.01 | -353.24 | -301.85 | 445.85 | 375.78 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 874 | -2,668 | -7,718 | -5,273 | 9,952 | 7,095 |
Capital Expenditures CapEx Growth | -605 | -448 | -526 | -804 | -277 | -193 |
Free Cash Flow Free Cash Flow Growth | 269 | -3,116 | -8,244 | -6,077 | 9,675 | 6,902 |
Free Cash Flow Growth | - | - | - | - | 40.18% | 50.70% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 76.05% | 72.32% | 73.59% | 75.70% | 94.05% | 94.73% |
Operating Margin | -10.86% | -27.92% | -22.97% | -81.46% | 18.06% | 39.01% |
Pretax Margin | -29.40% | -50.48% | -16.17% | -83.66% | 6.92% | 2.44% |
Profit Margin | -23.34% | -42.31% | -16.78% | -56.34% | 2.45% | 5.74% |
FCF Margin | 0.80% | -10.52% | -28.59% | -47.60% | 62.14% | 38.97% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 458.51 | 152.62 |
Forward PE | 30.81 | 14.88 | 48.75 | 62.51 | 62.98 | 37.67 |
P/FCF Ratio | 379.09 | - | - | - | 18.10 | 22.49 |
PS Ratio | 3.05 | 2.53 | 3.27 | 9.96 | 11.25 | 8.76 |